多发性硬化严重程度基因型在预测疾病病程中的相关性:一项真实世界队列研究
该研究在1455例多发性硬化患者的前瞻性队列中评估进展相关单核苷酸变异与临床表型的关联。未发现rs10191329A与临床相关结局相关,但重复了rs7289446G和rs868824C与固定残疾发展的关联,效应量中等。作者认为目前个体基因分型不太可能用于临床指导疾病管理。
要点
- 在1455例多发性硬化患者中,rs10191329A与临床相关结局均未发现关联。
- 重复了rs7289446G和rs868824C与固定残疾发展的关联,但效应量中等。
- 作者认为目前个体基因分型不太可能用于临床指导疾病管理。
核心结论
- 识别rs10191329A和其他提示性单核苷酸变异对理解多发性硬化严重程度的病理生理过程有重要意义。
- 目前个体基因分型不太可能用于临床指导疾病管理。
- 本研究显示对神经退行性疾病中与疾病进展相关的全基因组关联研究进行独立重复的重要性。
研究设计与样本
- 在1455例多发性硬化患者的前瞻性队列中评估进展相关单核苷酸变异与详细临床表型的关联。
- 使用逻辑回归、生存分析和倾向性评分匹配预测相关长期临床结局。
主要发现
- 未发现rs10191329A与一系列临床相关结局(如扩展残疾状态量表里程碑时间、年龄相关多发性硬化严重程度评分、起病或后续复发时解剖定位、年化复发率)存在关联。
- 使用倾向性评分匹配对基因型进行极端结局病例对照分析,未发现疾病严重程度与rs10191329A存在关联。
- 重复了两个提示性单核苷酸变异(rs7289446G和rs868824C)与固定残疾发展的关联,但效应量中等。
- 重复了HLA-DRB1*1501与起病年龄的关联。
临床怎么用
- 作者认为目前个体基因分型不太可能用于临床指导疾病管理。
- 原文未据此给出其他推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Currently, 233 genetic loci are known to be associated with susceptibility to multiple sclerosis (MS). Two independent pivotal severity genome-wide association studies recently found the first genome-wide significant single-nucleotide variant (SNV; rs10191329A ) and several other suggestive loci associated with overall disability outcomes. It is now important to understand if these findings can influence individual patient management. METHODS: We assessed whether these progression SNVs are associated with detailed clinical phenotypes in a well-characterized prospective cohort of 1,455 MS patients. We used logistic regression, survival analysis, and propensity score matching to predict relevant long-term clinical outcomes. RESULTS: We were unable to detect any association between rs10191329A and a range of clinically relevant outcomes (eg, time to Expanded Disability Status Scale milestones, age-related MS severity score, anatomical localization at onset or during subsequent relapses, annualized relapse rate). In addition, an extremes of outcome case-control analysis using a propensity score matching for genotype detected no association between disease severity and rs10191329A . However, we were able to replicate the association of two suggestive SNVs (rs7289446G and rs868824C ) with the development of fixed disability, albeit with modest effect sizes, and the association of HLA-DRB1*1501 with age at onset. INTERPRETATION: Identification of rs10191329A and other suggestive SNVs are of considerable importance in understanding pathophysiological processes associated with MS severity. However, it is unlikely that individual genotyping can currently be used in a clinical setting to guide disease management. This study shows the importance of independent replication of genome-wide association studies associated with disease progression in neurodegenerative disorders. ANN NEUROL 2024;95:459-470.
引用
- Kreft KL, Uzochukwu E, Loveless S, et al. Relevance of Multiple Sclerosis Severity Genotype in Predicting Disease Course: A Real-World Cohort. Ann Neurol. 2023. PMID: 37974536. doi:10.1002/ana.26831
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。